ArticleCancer immunology, immunotherapy : CII2022

Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma.

Kui Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.